Skip to main content
. 2022 Aug 25;13:985450. doi: 10.3389/fimmu.2022.985450

Figure 5.

Figure 5

Three-dimensional structure analysis, structure refinement, and structure validation of MPXV-V2. (A) The 3D model of the multi-epitope vaccine was built by the Swiss Model using a homology modeling approach. (B) Refine 3D structure of MPXV-V2 obtained from DeepRefiner web-server. (C) Ramachandran plot analysis shows 84.5% residues in the favored region, 13.4% residues in the allowed region, and 2.1% residues in the disallowed region of the plot. (D) ProSA-web results with a Z-score of -1.66.